Literature DB >> 29916745

Effects of hsa_circRBM23 on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression.

Baoyong Wang1,2, Hongwei Chen2, Chunfen Zhang2, Tian Yang2, Qiaofei Zhao2, Yifan Yan2, Yu Zhang2, Feng Xu1.   

Abstract

Primary hepatocellular carcinoma (HCC) is one of the most common malignant tumors. At present, the molecular mechanism of HCC remains unclear. A recent circular RNA (circRNA) profiling study showed that circRBM23 expression was upregulated in HCC tissues. Therefore, in this study, the impact of circRBM23 during the progression of HCC was evaluated. The expression levels of circRBM23 and miR-138 in HCC tissues and HCC cell lines were determined by RT-PCR and the results indicated that circRBM23 expression was increased in the HCC tissues and HCC cell lines, whereas miR-138 expression was decreased. An upregulation of circRBM23 expression in HCC cells was shown to increase cell viability, and also increased the ability of cells to migrate. Downregulation of circRBM23 was found to decrease cell viability, proliferation, and migration, and promote the expression of miR-138 and its related target genes, vimentin, and CCND3. Moreover, miR-138 was found to regulate HCC cell viability and migration, and the levels of vimentin and CCND3 protein expression were found to be inversely correlated with those of miR-138 expression. The downregulation of circRBM23 in HCC tissues can regulate the miR-138-mediated signal pathway by promoting miR-138 expression. The results in vivo demonstrated that circRBM23 is required for the tumorigenesis with downregulation of tumor suppressor miR-138. These data indicated that upregulated circRBM23 functioned as oncogene in HCC through regulating the tumor suppressor miR-138.

Entities:  

Keywords:  cell migration; cell viability; circRBM23; hepatocellular carcinoma; miR-138

Mesh:

Substances:

Year:  2018        PMID: 29916745     DOI: 10.1089/cbr.2017.2424

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  9 in total

1.  circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.

Authors:  Peng Li; Runjie Song; Fan Yin; Mei Liu; Huijiao Liu; Shuoqian Ma; Xiaomeng Jia; Xiaohui Lu; Yuting Zhong; Lei Yu; Xiru Li; Xiangdong Li
Journal:  Mol Ther       Date:  2021-08-25       Impact factor: 11.454

2.  Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin.

Authors:  Yi Li; Anqi Wu; Lin Chen; Aiting Cai; Yuhao Hu; Zhou Zhou; Qianyi Qi; Yixuan Wu; Donglin Xia; Peixin Dong; Shaoqing Ju; Feng Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-09-07

Review 3.  Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma.

Authors:  Man Wang; Fei Yu; Peifeng Li
Journal:  Cancers (Basel)       Date:  2018-08-02       Impact factor: 6.639

Review 4.  Functional roles of circular RNAs during epithelial-to-mesenchymal transition.

Authors:  Bing-Qing Shang; Min-Le Li; Hao-Yu Quan; Ping-Fu Hou; Zhong-Wei Li; Su-Fang Chu; Jun-Nian Zheng; Jin Bai
Journal:  Mol Cancer       Date:  2019-09-16       Impact factor: 27.401

Review 5.  Circular RNA is a popular molecule in tumors of the digestive system (Review).

Authors:  Hao-Ying Wang; Yu-Ping Wang; Xi Zeng; Ya Zheng; Qing-Hong Guo; Rui Ji; Yong-Ning Zhou
Journal:  Int J Oncol       Date:  2020-04-27       Impact factor: 5.650

Review 6.  Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.

Authors:  Wenkang Shang; Gabriel Komla Adzika; Yujie Li; Qike Huang; Ningding Ding; Bianca Chinembiri; Mohammad Sajjad Ibn Rashid; Jeremiah Ong'achwa Machuki
Journal:  Cancer Med       Date:  2019-09-15       Impact factor: 4.452

7.  Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis.

Authors:  Xi Yang; Qunxiong Zhang; Bugao Guan
Journal:  Onco Targets Ther       Date:  2020-11-06       Impact factor: 4.147

8.  Twist1 activated circRNA-10720 is a new player in hepatocellular carcinoma metastasis.

Authors:  Alfons Navarro
Journal:  Transl Cancer Res       Date:  2019-03       Impact factor: 1.241

9.  CircRNAs as Potential Blood Biomarkers and Key Elements in Regulatory Networks in Gastric Cancer.

Authors:  Laís Reis-das-Mercês; Tatiana Vinasco-Sandoval; Rafael Pompeu; Aline Cruz Ramos; Ana K M Anaissi; Samia Demachki; Paulo Pimentel de Assumpção; Amanda F Vidal; Ândrea Ribeiro-Dos-Santos; Leandro Magalhães
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.